Benjamin Roche
Promising future previewed for PAD treatment at Riga summit
This advertorial is sponsored by BD.
There has been major progress in the treatment of peripheral arterial disease (PAD) globally in the last few years,...
Severe obesity linked to lower AVF maturation rates
Researchers behind a new study published in the Annals of Vascular Surgery, among them lead author Laura Anderson and corresponding author Benjamin Brooke (both...
Enrolment completed in SAVE trial of Selution SLR for AVF treatment
MedAlliance has announced completion of patient enrolment in the SAVE clinical trial with the Selution Sustained Limus Release (SLR) 018 drug-eluting balloon (DEB) for...
Xeltis secures additional €12.5 million from European Innovation Council
Xeltis has announced the closing of an additional €12.5 million in funding from the European Innovation Council (EIC) Fund, set up by the European...
Merit Medical announces series of dialysis catheter acquisitions
Merit Medical Systems has announced that it has completed the acquisition of a portfolio of dialysis catheter products and the BioSentry biopsy tract sealant...
New UKKA guideline places patient choice at heart of vascular access...
The recent haemodialysis access guideline update from the UK Kidney Association (UKKA), which was published in the run-up to the 2023 UK Kidney Week...
Xeltis presents six-month first-in-human data on aXess graft
Xeltis has presented “highly-encouraging” six-month data from its first-in-human (FIH) aXess vascular graft trial at the 13th Congress of the Vascular Access Society (VAS;...
New data presented on IceCure cryoablation system for tumour treatment
IceCure, developer of the minimally-invasive cryoablation ProSense System which has shown promise in the treatment of renal masses, has announced that it has been...
ESRD strongly associated with adverse limb events in new study
A new investigation into the association between end-stage renal disease (ESRD) and major adverse limb events (MALEs) has found that not only is it...
Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial
A new trial of endovascular ultrasound-based renal denervation technology has found that it reduced blood pressure in hypertensive patients at two months. The RADIANCE...
IceCure release preliminary data on ProSense cryoablation system
IceCure Medical, developer of the minimally-invasive ProSense System for cryoablation, which destroys tumours by freezing, today announced interim results from the ICESECRET study for...
ABISS trial comparison finds DCB superior to plain-balloon angioplasty in per-protocol...
Data have been presented for the first time at the Paris Vascular Insights (PVI) conference (23–25 November, Paris, France) from the ABISS trial, which...
VentureMed to present new data on DCB treatment for PAD
VentureMed Group has announced new data presentations on the treatment of peripheral arterial disease (PAD) with drug-coated balloon (DCBs) in addition to 12-month AV...